Skip to main content

Norethindrone Acetate and Ethinyl Estradiol Medicare Part D Coverage

Brand name: Tri-Legest Fe 28 Day 28 Day
Dosage form
KIT
84%
of Medicare Part D plans
cover Norethindrone Acetate and Ethinyl Estradiol
4,638 of 5,530 plans
2.5
Avg. formulary tier
$11.00
Median 30-day copay
$0.00–$22.00
Copay range

Formulary Tier Distribution

How Medicare Part D plans classify Norethindrone Acetate and Ethinyl Estradiol. Lower tiers = lower copays.

Tier 1 - Preferred Generic 3%
145 plans • avg $0.00/mo
Tier 2 - Generic 59%
2,756 plans • avg $0.51/mo
Tier 3 - Preferred Brand 22%
1,031 plans • avg $0.37/mo
Tier 4 - Non-Preferred Drug 15%
706 plans • avg $33.58/mo

Find the cheapest plan for Norethindrone Acetate and Ethinyl Estradiol

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for Norethindrone Acetate and Ethinyl Estradiol →

Get Norethindrone Acetate and Ethinyl Estradiol Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

Norethindrone Acetate and Ethinyl Estradiol Medicare Coverage by State

Coverage rates and average costs vary significantly by state. Click a state to see the specific plans available there.

Frequently Asked Questions about Norethindrone Acetate and Ethinyl Estradiol

84% of Medicare Part D plans cover Norethindrone Acetate and Ethinyl Estradiol. It is most commonly placed on Tier 3. Coverage varies by plan and geographic area.

The median 30-day copay for Norethindrone Acetate and Ethinyl Estradiol on Medicare Part D is $11.00 at a preferred pharmacy. Costs range from $0.00 to $22.00 depending on the plan.

Norethindrone Acetate and Ethinyl Estradiol is placed on Tier 3 by most Medicare Part D plans. Lower tier numbers generally mean lower copays.

0% of plans require prior authorization for Norethindrone Acetate and Ethinyl Estradiol. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →